Clinical Evaluation of TrueVision System: LRI and Capsulorhexis Templates
NCT ID: NCT01123343
Last Updated: 2015-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
35 participants
INTERVENTIONAL
2010-01-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rayner Toric IOL Rotational Stability
NCT02393313
Limbal Relaxing Incision Versus Toric Intraocular Lens for Corneal Astigmatism During Cataract Surgery.
NCT02067429
Effect of TrueTear Corneal Surface Imaging
NCT03637348
Observational Study - TA- 2025-1
NCT07007897
Post-market Study to Obtain Surgeon Feedback on Clinical Outcome in Eyes Implanted With TECNIS Toric II IOL
NCT04210232
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LRI Templates
To evaluate the ability of the TRUEVISION 3D VISUALIZATION AND GUIDANCE SYSTEM FOR MICROSURGERY to provide the ophthalmic surgeon appropriate alignment, orientation and sizing information during cataract or refractive lens exchange surgery compared to the current standard of care (manual markings or heuristic techniques) for LRI.
TrueVision 3D Visualization and Guidance System for MicroSurgery
Adjunct imaging tool (to the microscope oculars) that provides onscreen video guidance for alignment, orientation, and sizing during eye surgery, based on a surgeon's defined nomogram
Capsulorhexis Templates
To evaluate the ability of the TRUEVISION 3D VISUALIZATION AND GUIDANCE SYSTEM FOR MICROSURGERY to provide the ophthalmic surgeon appropriate alignment, orientation and sizing information during cataract or refractive lens exchange surgery compared to the current standard of care (manual markings or heuristic techniques) for Capsulorhexis.
TrueVision 3D Visualization and Guidance System for MicroSurgery
Adjunct imaging tool (to the microscope oculars) that provides onscreen video guidance for alignment, orientation, and sizing during eye surgery, based on a surgeon's defined nomogram
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TrueVision 3D Visualization and Guidance System for MicroSurgery
Adjunct imaging tool (to the microscope oculars) that provides onscreen video guidance for alignment, orientation, and sizing during eye surgery, based on a surgeon's defined nomogram
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Natural lens for which phacoemulsification extraction and posterior IOL implantation is planned
* Clear intraocular media other than cataract
* Potential visual acuity 20/30 or better
* Able to comply with preop and postop examination procedures
* Signed and dated informed consent
Exclusion Criteria
* Corneal pathology potentially affecting topography including corneal degeneration
* Irregular astigmatism
* Macular degeneration or any other macular disease which reduces potential acuity
* Previous corneal surgery (including LASIK, radial keratotomy, penetrating keratoplasty, etc)
* Use of systemic or ocular medications that affects vision
* Acute or chronic systemic or ocular disease or illness that would increase risk or confound study results
* Use of Flomax or any other medication which negatively impacts surgical outcomes
* History of ocular trauma or ocular surgery
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TrueVision Systems, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Packer, MD
Role: STUDY_DIRECTOR
Oregon Eye Associates
Robert Weinstock, MD
Role: PRINCIPAL_INVESTIGATOR
Eye Institute of West Florida
Jason Stahl, MD
Role: PRINCIPAL_INVESTIGATOR
Durrie Vision
Douglas Katsev, MD
Role: PRINCIPAL_INVESTIGATOR
Sansum Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Drs. Fine, Hoffman and Packer
Eugene, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TVS-2009-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.